WNT3 and colorectal carcinoma: A prior study has provided confirmation that YHJD effectively inhibits epithelial-mesenchymal transition and stem-cell formation in CRC by modulating the hsa-miR-374a-3p/Wnt3/β-catenin signaling pathway 27.